Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Microsoft
MSFT
|
$981M |
| 2 |
Chevron
CVX
|
$718M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
$469M |
| 4 |
Shopify
SHOP
|
$439M |
| 5 |
Meta Platforms (Facebook)
META
|
$401M |
Top Sells
| 1 |
Amazon
AMZN
|
$675M |
| 2 |
New Oriental
EDU
|
$673M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
$633M |
| 4 |
Tesla
TSLA
|
$543M |
| 5 |
Verizon
VZ
|
$535M |
Sector Composition
| 1 | Healthcare | 19.41% |
| 2 | Technology | 16.81% |
| 3 | Consumer Staples | 11.14% |
| 4 | Consumer Discretionary | 10.11% |
| 5 | Financials | 8.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
Shopify
SHOP
$183B
| $439M | 0.52% |
+14,036,600
| New | +$439M |
|
27
GSK
GSK
$79.5B
| $434M | 0.51% |
9,979,321
-32,600
| -0.3% | -$1.42M |
|
|
ATVI
28
DELISTED
Activision Blizzard Inc.
ATVI
| $419M | 0.5% |
5,377,098
+1,861,500
| +53% | +$145M |
|
29
Advanced Micro Devices
AMD
$262B
| $407M | 0.48% |
5,320,160
-1,787,130
| -25% | -$137M |
|
30
Incyte
INCY
$16.9B
| $391M | 0.46% |
5,142,733
+445,100
| +9% | +$33.8M |
|
31
Colgate-Palmolive
CL
$67.3B
| $390M | 0.46% |
4,872,486
-816,300
| -14% | -$65.4M |
|
32
AstraZeneca
AZN
$254B
| $387M | 0.46% |
5,859,072
+1,297,244
| +28% | +$85.7M |
|
33
NIO
NIO
$13.9B
| $386M | 0.46% |
17,768,900
+12,367,300
| +229% | +$269M |
|
34
Union Pacific
UNP
$130B
| $381M | 0.45% |
1,785,599
+767,300
| +75% | +$164M |
|
35
Roblox
RBLX
$92.4B
| $381M | 0.45% |
11,580,582
+7,143,300
| +161% | +$235M |
|
36
American Express
AXP
$225B
| $373M | 0.44% |
2,690,194
+2,638,094
| +5,064% | +$366M |
|
37
Vodafone
VOD
$28.2B
| $373M | 0.44% |
23,913,676
-3,624,256
| -13% | -$56.5M |
|
38
Exelixis
EXEL
$9.97B
| $370M | 0.44% |
17,783,937
+921,659
| +5% | +$19.2M |
|
39
Altria Group
MO
$111B
| $367M | 0.43% |
8,775,416
+5,003,900
| +133% | +$209M |
|
|
ABMD
40
DELISTED
Abiomed Inc
ABMD
| $358M | 0.42% |
1,446,523
+32,323
| +2% | +$8M |
|
41
Amgen
AMGN
$153B
| $350M | 0.41% |
1,439,745
+1,060,200
| +279% | +$258M |
|
42
General Mills
GIS
$26.4B
| $345M | 0.41% |
4,575,588
+143,900
| +3% | +$10.9M |
|
43
Regeneron Pharmaceuticals
REGN
$61B
| $345M | 0.41% |
583,062
+303,200
| +108% | +$179M |
|
44
CSX Corp
CSX
$59.8B
| $335M | 0.4% |
11,529,500
+5,151,100
| +81% | +$150M |
|
45
Novartis
NVS
$248B
| $320M | 0.38% |
3,783,370
+402,200
| +12% | +$34M |
|
46
Workday
WDAY
$62.4B
| $317M | 0.38% |
2,274,400
+1,980,629
| +674% | +$276M |
|
47
Biogen
BIIB
$20.8B
| $315M | 0.37% |
1,546,007
+501,800
| +48% | +$102M |
|
48
Moderna
MRNA
$9.38B
| $312M | 0.37% |
2,184,141
-1,634,039
| -43% | -$233M |
|
|
B
49
Barrick Mining Corporation
B
$46.4B
| $309M | 0.37% |
17,457,214
+8,102,178
| +87% | +$143M |
|
50
Domino's
DPZ
$15.9B
| $309M | 0.37% |
791,925
-248,900
| -24% | -$97M |
|